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Abstract 
Background: The development of antibiotic resistance by bacteria is of global concern. 
Inappropriate prescribing has the potential to exacerbate this issue. We aimed to examine 
the patterns of prescribing of antimicrobial medicines by dental practitioners in Australia 
from 2001 to 2012. 
Methods: Data were collected from Medicare Australia on prescriptions from dental 
practitioners dispensed to concessional beneficiaries between 2001 and 2012. We examined 
patterns of use over time. 
Results: There was an overall increase in number of prescriptions and in dispensed use 
(standardised by dose and population) of antibiotics and antifungals for the concessional 
population over the 12 year period. The use of dentally prescribed antibiotics increased 
50%. Amoxycillin was the most commonly prescribed antibiotic accounting for 66% of all 
prescriptions in 2012. Generally, there was preferential prescribing of the highest dose 
formulations. The use of the two antifungals increased 30% over the study period with a 
preference for amphotericin B (74%) rather than nystatin.   
Conclusions: This data shows a concerning increase in prescribing of antibiotics and 
antifungals by dentists in Australia. It would appear that Australian dentists may not be 
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prescribing these medicines appropriately, however further research is needed to 
understand prescribing behaviours and decision making by dentists. 
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Introduction 
Australian dentists prescribe antibacterial and antifungal medicines to treat oral and dental 
infections.1 While antimicrobials are an important adjunct to the management of some 
dental conditions, it is critical that their use is judicious. Increasing antibiotic consumption at 
the population level is associated with the development of antibiotic resistance2 and this 
issue is of global concern.3 Although the contribution of dental prescribing of antimicrobials 
to the emergence of resistance is unknown, indiscriminate prescription of antibiotics has 
been identified as a major factor in its development.3 Unnecessary prescribing of antibiotics 
also exposes patients to the risk of adverse reactions and increases costs associated with 
dental care. 
 
Indications for dental prescribing of antimicrobials are limited because most dental 
infections are effectively treated with direct operative intervention, and antimicrobials are 
used only occasionally and as an adjunct.4 However, when required, appropriate prescribing 
of a well chosen antimicrobial can prevent potentially life threatening sequelae of dental 
infections. In addition, certain patients (those with a narrow range of cardiac conditions) 
who are undergoing some invasive dental procedures require antibiotic prophylaxis to 
prevent endocarditis.1 The guidelines for dental prescribing can be found in the Australian 
Therapeutic Guidelines (Oral and Dental; ATG).1 There is evidence to suggest that dental 
practitioners may not adhere to clinical guidelines and tend to overprescribe antibiotics.5-9  
 
Antibacterial medicines are the most commonly prescribed antimicrobials in dentistry.4 A 
narrow spectrum penicillin such as phenoxymethylpenicillin is the drug of choice for acute 
odontogenic infections as recommended by the ATG. 1 While narrow in spectrum, it is 
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effective against 85% of oral bacteria (mainly Gram positive organisms). The ATG suggest 
amoxicillin as a second preference for this indication. Although it has a somewhat broader 
spectrum (effective against 91% of oral bacteria), its use in the treatment of dental 
infections is discouraged in order to reduce the development of resistance in Streptococcus 
pneumoniae. Amoxycillin is also more likely to cause adverse effects such as gastrointestinal 
problems and rashes.1 Where penicillin is not tolerated, clindamycin or lincomycin is 
recommended. Penicillins are inactivated by the beta-lactamase enzyme produced by some 
organisms.10 The addition of clavulanate inhibits this enzyme and increases the spectrum of 
activity of the antibiotic. Amoxycillin plus clavulanate combinations however should not be 
the first line of treatment for odontogenic infections, where a narrow spectrum antibiotic is 
likely to be as effective and to present less risk of adverse reactions.11 Metronidazole is 
effective against infections caused by anaerobic bacteria and is the recommended antibiotic 
for spreading neck infections and acute ulcerative gingivitis. It can be given in combination 
with a penicillin for severe or unresponsive infections.1 
 
Fungal infections affect a substantial and increasing proportion of the population.12 
Candidosis is the commonest oral fungal infection. Treatment includes topical polyene 
(nystatin or amphotericin) or azole (miconazole) antifungal medications.13 Resistance to 
polyene antifungals is rare but some species of Candida are less susceptible to azole 
antifungals and Candida albicans can acquire resistance.12 These medicines are widely used 
but there is scant information on dental prescribing trends. Topical antiviral medicines such 
as acyclovir are used to treat herpes simplex viral infection of the lips.1 These ointments are 
available over the counter (OTC) in Australia. 
 
Dental use of antibiotics has previously been examined with a focus on knowledge, 
indications and preference.5-7, 9, 14, 15 Only two studies have investigated longitudinal 
prescribing trends, in Norway 16 and the Czech Republic.16, 17 We aimed to describe the 
dispensed use of antimicrobial medicines prescribed by dental practitioners in concessional 
beneficiaries in Australia from 2001 to 2012. 
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Methods 
The medicines considered in this study are those listed only for dental prescribing. All the 
medicines were available under the Australian Government’s subsidised medicine 
formulary, the Pharmaceutical Benefits Schedule (PBS). The PBS provides a broad range of 
registered medicines to Australian citizens with two levels of patient co-payments: general 
(AUD$37.70, 2015) and concessional (AUD$6.10, 2015).18 Concessional beneficiaries are 
those who receive social security benefits because they hold a Pensioner card, a Health Care 
card, or a Commonwealth Seniors Health card. Most of the medicines of interest are priced 
under the general co-payment in any year and these are not recorded by the Department of 
Human Services who administers the scheme. As data on the dispensed use of medicine for 
general patients is not available we analysed data for concessional patients only.19 We 
obtained dispensed medicine use data from publically available sources provided by the 
Department of Human Sevices.20 We collected data for each formulation of each medicine 
between January 2001 and December 2012. The amount of medicine dispensed (as 
prescriptions) was standardised using the defined daily dose (DDD) per 1,000 population per 
day. The DDD, as established by the World Health Organization Collaborating Centre for 
Drug Statistics Methodology, is the assumed average maintenance dose per day (expressed 
in terms of the dose contained in marketed dosage forms) for a medicine used for its main 
indication in adults.21 We obtained the concessional population values from the Department 
of Social Services annual reports and calculated the proportion of concessional beneficiaries 
using the mid-year Australian resident population.22, 23 There were no values for the 
population of concessional beneficiaries for the financial year 2011-2012.22 We estimated 
the population by extrapolating the average of the proportion of dependants to primary 
card holders for 2008 to 2010. We were not able to collect information on the dispensed 
items prescribed by dentists who may also have medical registration and prescribe using 
their medical prescriber number (e.g. maxillofacial surgeons). These PBS data do not capture 
those medicines prescribed to inpatients in public hospitals.19 We suggest that both these 
sources of dispensed use would be quite small in relation to dispensed use of dental items in 
the wider community. 
 
We calculated dispensed medicine use for all dentally prescribed antibacterial (amoxicillin, 
amoxicillin plus clavulanic acid, ampicillin, benzylpenicillin, benzathine benzylpenicillin, 
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cefaclor, cefotaxime, cefuroxime, cephalexin, clindamycin, chloramphenicol, dicloxacillin, 
doxycyclin, erythromycin, flucloxacillin, lincomycin, metronidazole and 
phenoxymethylpenicillin, procaine penicillin, roxithromycin [listed in 2010], ticarcillin plus 
clavulanic acid, trimethoprim plus sulfamethoxazole, and vancomycin) and antifungal 
medicines (amphotericin B and nystatin). We calculated the proportion of dental (vs. all 
other medical excluding emergency doctor supplies) prescribing for the major medicines 
from each class (summed across all dose formulations) for all beneficiaries for the 
cumulative five year period from 2008 to 2012. The medicines were: amoxicillin, 
metronidazole, amoxicillin plus clavulanic acid, and amphotericin B. All calculations and 
graphs were completed using Microsoft Office Excel 2010. 
 
Results 
The concessional beneficiary (including dependents) population was 6,693,446 in 2001 and 
increased to 7,684,132 in 2012. The proportion of concessional beneficiaries to total 
population ranged from 32% to 36 % in any one year and the average was 34% over the 12 
year period. The antibacterial medicine most frequently prescribed by dental practitioners 
was amoxicillin and for antifungal medicines this was amphotericin B (Table 1). The 
proportion of prescribing by dental practitioners (vs all other medical prescribers) was 
substantial. Almost one in six (15.33%) dispensings for metronidazole were prescribed by 
dentists as were one in nine dispensings of amoxicillin (11.37%). The proportion of 
prescribing by dental practitioners was low for amoxycillin plus clavulanic acid (1.07%) and 
amphotericin B (2.35%). 
 
Antibacterials 
Dispensed (standardised) use of antibacterials increased by 50% to 1.032 DDD/1,000 
concessional beneficiaries/day (number of prescriptions increased by 57%). Amoxicillin 
accounted for two thirds (66.3%) of all antibacterial prescriptions in 2012, followed by 
metronidazole (13.6%), amoxicillin plus clavulanic acid (7.1%), and clindamycin (6.1%). 
These four medicines accounted for nine in ten (93%) antibiotic prescriptions by dentists in 
2012.  
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Amoxicillin use increased by 49% over 12 years (average annual increase 3.8%; Fig. 1). The 
use of the 500mg capsule increased from 70% to 90% of all amoxicillin prescriptions over 
the period whereas the use of the 250mg capsule decreased from 26% to 6% over the same 
period. There was negligible use of the other dose formulations. Amoxicillin plus clavulanic 
acid use increased 197% over 12 years (average annual increase 16.48%; 20% per year for 
prescriptions; Fig. 1). The higher dose formulation (875mg/125mg) was the most commonly 
used (78%) in 2012 and use of this product increased threefold to 0.0073 DDD/1,000 
concessional beneficiaries/day.   
 
Metronidazole dispensed use increased 49% over the study period to 0.059 DDD/1,000 
concessional beneficiaries/day in 2012. The use of the two main dose formulations changed 
over time. In 2001, the 200mg tablet was the preferred formulation (68% of prescriptions) 
but in 2012 the 400mg tablets were more widely used (58% of prescriptions). Use of the 
other dose formulations was negligible. Clindamycin use increased three-fold to 0.0241 
DDD/1,000 concessional beneficiaries/day in 2012 (317% increase in dispensed use, 380% 
increase in prescriptions). Use of cephalexin increased 49% over time but use of 
erythromycin, phenoxymethylpenicillin and doxycycline decreased. 
 
Antifungals 
Dispensed use of the two antifungal medicines increased 30% to 0.0073 DDD/1,000 
concessional beneficiaries/day (2.5% average annual increase). Amphotericin B constituted 
74% of antifungal use in 2012 with the remainder being nystatin (Table 1). Only one 
formulation of amphotericin B was subsidised and use increased 30% over 12 years. There 
were two dose formulations for nystatin with the oral liquid dose form accounting for 92% 
in 2012. 
 
Discussion 
This study shows that dispensed use of antibiotics by dental practitioners in Australia has 
increased over the last decade. Two in three antibacterial dental prescriptions were for 
amoxicillin. Dispensed use of clindamycin and amoxycillin plus clavulanic acid increased 
three-fold and two-fold, respectively. Antifungal use increased substantially and three in 
four dental prescriptions were for amphotericin B.  
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In comparison with the Czech Republic, use of antibacterials in dental practice in Australia is 
somewhat higher. In Australia use increased from 0.69 to 1.03 DDD/1,000 concessional 
beneficiaries/day between 2001 and 2012. Over the period 2006 to 2012, use in the Czech 
Republic increased from 0.63 to 0.75 DDD/1,000 inhabitants/day.17 Prescriptions written by 
general dental practitioners as a proportion of all community antibiotic consumption are 
significant. In the current study, dental prescribing of metronidazole was 15.3% and for 
amoxicillin it was 11.4%. Other studies have shown that for antibacterials as a whole, dental 
prescribing comprises 7% in England (1999),8 8% in the Czech republic (2012),17 8% in 
Norway (2005),16 and 9% in Wales (2008).24  
 
Prescribing preferences of dentists in this Australian study have shown that amoxycillin and 
metronidazole are the most frequently used antibiotics. This is similar to data from England 
where 78% of all dental prescriptions for antibiotics were for one of these two medicines 8 
and Wales where penicillins comprised 67% of all dentally prescribed antibiotics.24 In 
Norway however, prescribing preferences of dentists are very different, with 
phenoxymethylpenicillin comprising 75% of all dental antibiotic prescriptions16. The dental 
use of this medicine in Norway is 47 times higher than in Australia. Correspondingly, dental 
use of amoxicillin in Norway is 19 times less than in Australia (use is 0.0427 vs 0.8240 
DDD/1,000 population/day).  
 
The preference of amoxicillin by Australian dentists does not reflect the guidance provided 
by the ATG1 for management of acute odontogenic infections. Similarly, the narrow range of 
cardiac and other conditions recommended for antibiotic prophylaxis prior to dental 
treatment1 does not explain the size and proportion of dental prescribing of this medicine. 
Amoxicillin was also found to be the antibiotic of choice in a previous survey of 61 South 
Australian dentists.5 This earlier study also noted a self-reported preference to use lower 
dose antibiotics.5 The results of the present study however show that dentists are 
preferentially prescribing higher dose formulations than in the past. This is aligned with ATG 
guidance that when antibiotics are used, they should be used in appropriately high doses 
and over the minimum period of time.1 Additionally, it appears that clindamycin is being 
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substituted for erythromycin where penicillin is not tolerated, and this is in agreement with 
the guidelines.1 
 
Both amphotericin B and nystatin are widely used for the treatment of oral candidosis.25 
They can cause gastrointestinal disturbances despite being poorly absorbed in the gut.25 We 
showed a modest increase in the dispensed use of antifungal medicines and three in four 
prescriptions were for amphotericin B. In a self-reported survey of 297 English dentists, 
nystatin was the preferred antifungal followed by miconazole, amphotericin B and 
fluconazole (neither azole antifungal is subsidised in Australia).25 
 
This strength of this study is that it represents the first thorough examination of all 
subsidised dispensing of medicines prescribed by dentists to Australian concessional 
beneficiaries. Its longitudinal analysis of dental prescribing provides a useful overview of 
changes over time as well as insights as to whether the clinical guidelines are being adhered 
to. Limitations of this study are that data were only available for concessional beneficiaries 
(who account for about one third of the population) and so these values substantially 
underestimate the total dental prescribing of these medicines in the wider community. 
Differences exist in oral health status and dental attendance patterns for the concessional 
versus the general population26 and so standardised values for medicine use in the 
concessional population may not be directly comparable to those for the general 
population. Future research should determine dental prescribing for both populations. The 
Department of Health has recently provided data which could be used for this purpose 
(http://www.pbs.gov.au/info/browse/statistics). Dispensed prescription data does not allow 
analysis of actual consumption for the individual prescribed the medicine. Further 
investigation of patient behaviours is required. These are aggregated data and there was no 
information on the reason for the prescription, duration of treatment, frequency of repeat 
administration and co-administration of multiple antibiotics in the same patient. We were 
not able to collect data for those patients who might be prescribed antimicrobials from a 
general practitioner for dental issues. There are considerable challenges in determining the 
use of OTC medicines in managing dental conditions. Additional studies are needed to 
ascertain the clinical reasoning which leads a dentist to prescribe a particular medicine and 
to determine the extent to which the clinical guidelines are adhered to. 
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Practitioners do appear to have responded to some of the recommendations in the clinical 
guidelines, but not all. The authors suggest that regular continuing education for dental 
practitioners in the safe and appropriate use of medicines should be mandatory. Other 
mechanisms to inform, regulate and monitor dental prescribing practices should also be 
considered. Medication safety is one of the six National Safety and Quality Health Services 
Standards 27 which must be addressed in order to obtain accreditation of a dental practice. 
While at this stage accreditation of private dental practices is not mandatory, it would assist 
in enhancing safety and quality in use of medicines by dental practitioners. Regular 
surveillance of dental prescribing would also provide feedback to the profession on 
compliance with the guidelines. 
 
Conclusion 
Dental practitioners are significant prescribers of antibiotics in Australia. There has been an 
increase in the use of antibiotic and antifungal medicines over the last 12 years. In addition 
to the risk of ineffective treatment and adverse reactions for the individual, inappropriate 
prescribing of antibiotics, including by dentists, can accelerate the development of resistant 
bacterial strains, a problem of potentially global proportions.   
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Tables and Figures 
Table 1. Total concessional prescriptions (n), percent of category (%), use (DDD/1,000 
concession beneficiaries/day) and percent change (2001-2012) in standardised use of 
antibacterials and antifungals for 2001, 2007 and 2012 
 
Medicine 2001 2007 2012 % change n % Use n % Use n % Use 
ANTIBACTERIAL
S           
Amoxycillin 160,632 68.7 0.5520 198,345 66.7 0.7110 244,220 66.3 0.8240 49.3 
Metronidazole 33,572 14.4 0.0380 42,415 14.3 0.0516 50,005 13.6 0.0590 55.2 
Amoxycillin + 
clavulanic acid 7,688 3.3 0.0248 14741 5.0 0.0456 26118 7.1 0.0737 196.9 
Clindamycin 4,702 2.0 0.0058 14,331 4.8 0.0169 22,584 6.1 0.0241 317.2 
Cephalexin 7,042 3.0 0.0124 9,942 3.3 0.0177 11,184 3.0 0.0184 48.7 
Erythromycin 10,512 4.5 0.0255 9,846 3.3 0.0224 7,346 2.0 0.0150 -40.9 
Phenoxymethyl-
penicillin 6,190 2.6 0.0213 4,548 1.5 0.0161 3,746 1.0 0.0127 -40.5 
Doxycyclin 1,996 0.9 0.0057 2,022 0.7 0.0056 1,176 0.3 0.0029 -48.8 
Roxithromycin - - - - - - 834 0.2 0.0015 -- 
Trimethoprim + 
sulfamethoxazole 786 0.3  515 0.2  430 0.1   
Cefaclor 526 0.2 0.0008 464 0.2 0.0007 320 0.1 0.0004 -46.6 
Flucloxacillin 112 0 0.0002 132 0 0.0003 134 0 0.0003 10.0 
Dicloxacillin 44 0 0.0001 29 0 0.0001 42 0 0.0001 -6.3 
Chloramphenicol 17 0 0.0000 20 0 0.0000 17 0 0.0000 -13.1 
Cefuroxime 26 0 0.0001 37 0 0.0001 12 0 0.0000 -59.9 
Benzylpenicillin 80 0 0.0000 94 0 0.0000 4 0 0.0000 -91.3 
Benzathine 
Benzylpenicillin 0 0 0 0 0 0 2 0 0.0000  
Lincomycin 3 0 0.0000 0 0 0 1 0 0.0000 -71.0 
Procaine Penicillin 9 0 0.0000 3 0 0.0000 1 0 0.0000 -90.3 
Ticarcillin + 
clavulanic acid 0 0 0 0 0 0 0 0 0.0000 -- 
Ampicillin 9 0 0.0000 2 0 0.0000 0 0 0 -- 
Cefotaxime 4 0 0.0000 0 0 0 0 0 0 -- 
Vancomycin 1 0 0.0000 0 0 0 0 0 0 -- 
Total 
Antibacterials 233,951 100 0.6868 297,486 100 0.8878 368,176 100 1.0322 50.3 
ANTIFUNGALS 
          
Amphotericin B 2,284 77.5 0.0047 2389 79.1 0.0047 2474 73.7 0.0061 30.6 
Nystatin 662 22.5 0.0010 632 20.9 0.0008 884 26.3 0.0012 25.5 
Total Antifungals 2,946 100 0.0057 3021 100 0.0055 3358 100 0.0073 29.7
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Figure 1. Dispensed use (DDD/1,000 concession beneficiaries/day) of the four major 
antibiotics prescribed by dental practitioners between 2001 and 2012: amoxicillin, 
metronidazole, amoxicillin plus clavulanic acid, and clindamycin 
 
 
 
 
